Latest Breaking News On - Glac biotech co ltd - Page 1 : comparemela.com

COSTA MESA, Calif., Aug. 29, 2023 (GLOBE NEWSWIRE) AiViva Biopharma Inc., a clinical-stage biotechnology company developing innovative therapies to address major unmet medical needs, today announced the appointment of Mr. Jung-Chin (Rongjin) Lin to its board of directors. He is Honorary President of Center Laboratories, Inc. and Chairman of the Board of Lumosa Therapeutics Co., Ltd. and Glac Biotech Co., Ltd. He also serves as a Board member at Adimmune Corp. and BioGend Therapeutics Co., Ltd

Hong kongUnited statesT ai peiAiviva biopharmaJung chin rongjin linDiane tang liuAdimmune corpAiviva holdingPharmaengine incAiviva biopharma incMedeon biodesign incCenter laboratories incBoard of mycenax biotech incBiogend therapeutics co ltdBoard of lumosa therapeutics co ltdTaipei medical university